Last reviewed · How we verify

NCT06997419

Dexamethasone Palmitate for PONV After Open Surgery

Recruiting now NA Last updated 23 September 2025
What this trial tests

NA trial testing Dexamethasone Palmitate in Postoperative Nausea and Vomiting in 500 participants. Currently enrolling.

Timeline
1 July 2025
Primary endpoint
30 November 2026
31 December 2026

Quick facts

Lead sponsorBeijing Tiantan Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment500
Start date1 July 2025
Primary completion30 November 2026
Estimated completion31 December 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Beijing Tiantan Hospital

Who can join

Adults 18 to 65, any sex, with Postoperative Nausea and Vomiting or Dexamethasone Palmitate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dexamethasone is almost one of the most commonly used drugs for postoperative nausea and vomiting (PONV) prevention. However, PONV is still a complex problem to be solved; for example, even with preoperative dexamethasone administration, there are still some patients still experience PONV within 24 hours postoperatively. Compared to dexamethasone, dexamethasone palmitate has a long-lasting anti-inflammatory effect, 2-5 times that of traditional water-soluble dexamethasone, with fewer adverse effects. This trial aims to assess the effect and safety of preoperative dexamethasone palmitate on PONV after open surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dexamethasone Palmitate

Trials testing the same drug.

Other recruiting trials for Postoperative Nausea and Vomiting

Currently open trials in the same condition.

Other Beijing Tiantan Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06997419.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing